HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Chimerix (NASDAQ:CMRX) and maintained an $11 price target.
March 01, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on Chimerix with an $11 price target.
The reiteration of a Buy rating and maintenance of an $11 price target by a reputable analyst could positively influence investor sentiment towards CMRX, potentially driving its stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100